NCT03654573 - The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

December 18, 2024

Study Completion Date

December 18, 2024

Conditions

STEMI - ST Elevation Myocardial InfarctionMicrovascular Obstruction

Interventions

DEVICE

CorFlow Controlled Flow Infusion System - CoFI™

The CorFlow CoFI™ System is intended to assess the dynamic microvascular resistance and to treat microvascular obstruction in the coronary vasculature of patients following PCI with stent placement.

Trial Locations (8)

6900

Cardiocentro Ticino, Lugano

8091

UniversitätsSpital Zürich, Zurich

50161

The Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos, Kaunas

08661

Vilnius University Hospital Santariskiu Klinikos, Vilnius

Unknown

Inselspital Bern, Bern

HUG Geneva, Geneva

CHUV Lausanne, Lausanne

Leeds Teaching Hospitals NHS Trust, Leeds